Home » Topics » Disease categories and therapies » Infection

Infection
RSS

PS-15 as monotherapy comparable to trimethoprim/sulfamethoxazole in mice with PCP

Dec. 9, 1999

Highlights from ASTMH meeting: iron chelator with potential in drug-resistant malaria

Dec. 9, 1999

Abbott acquires U.S. marketing rights to cefdinir

Dec. 9, 1999

Antifungal collaboration extended by Genome Therapeutics and Schering-Plough

Dec. 9, 1999

MediGene and Epitome enter licensing agreement for genital warts ointment

Dec. 9, 1999

New cephalosporins from Toyama active against resistant strains

Dec. 8, 1999

Novel echinocandin B tested in neutropenic rabbit model of disseminated candidiasis

Dec. 7, 1999

Kyorin discusses design of anti-MRSA cephalosporins with affinity for PBP2'

Dec. 6, 1999

Pfizer presents novel hygromycin derivatives with antibacterial/antiprotozoal properties

Dec. 6, 1999

Schering-Plough to manufacture Ampligen for HemispheRx

Dec. 6, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.